Evidence map›Paper›PMID 15181236›Full record

ReviewMolecular neurobiology2004

Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection.

Hiroshi Masutani, Jie Bai, Yong-Chul Kim, Junji Yodoi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. The Role of the Thioredoxin System in Brain Diseases.Antioxidants (Basel, Switzerland) · 2022
    Review
  3. Thioredoxin-1 inhibits amyloid-βMolecular biology reports · 2022
    Article
  4. Review
  5. Article
  6. Progress in the mechanism and targeted drug therapy for COPD.Signal transduction and targeted therapy · 2020
    Review
  7. Article
  8. Article
  9. The Role of Astrocytes in Multiple Sclerosis.Frontiers in immunology · 2018
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Identification of novel nuclear targets of human thioredoxin 1.Molecular & cellular proteomics : MCP · 2014
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hiroshi MasutaniInstitute for Virus Research, Kyoto University, Sakyo, Kyoto, Japan. hmasutan@virus.kyoto-u.ac.jp
Jie Bai
Yong-Chul Kim
Junji Yodoi
Kyoto University · JPNational Institute of Advanced Industrial Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress has been implicated in the pathogenesis of a wide variety of neuronal diseases, including ischemic neuronal injury, Alzheimer's disease, and Parkinson's disease. Thioredoxin reduces exposed protein disulfides and couples with peroxiredoxin to scavenge reactive oxygen species. Nerve growth factor (NGF) has profound effects on neurons, including promotion of survival and differentiation via multiple signaling pathways. As for the NGF-induced neurite outgrowth, the CREB-cAMP responsive element (CRE) pathway is important to the activation of immediate-early genes such as c-fos. Thioredoxin is upregulated by NGF through ERK and the CREB-CRE pathway in PC12 cells. Thioredoxin is necessary for NGF signaling through CRE leading to c-fos expression and also plays a critical role in the NGF-mediated neurite outgrowth in PC12 cells. Therefore, thioredoxin appears to be a neurotrophic cofactor that augments the effect of NGF on neuronal differentiation and regeneration. NGF acts also as a neuronal survival factor. Previous reports showed that thioredoxin exerts a cytoprotective effect in the nervous system. The cytoprotective effect is mediated by enhancing the action of NGF, via the regulation of antiapoptotic signaling, or through its antioxidative stress activity.

Indexed as

AnimalsApoptosisCell SurvivalCyclic AMP Response Element-Binding ProteinHumansNerve Growth FactorNeurodegenerative DiseasesNeuroprotective AgentsOxidative StressThioredoxinsCyclic AMP Response Element-Binding ProteinNerve Growth FactorNeuroprotective AgentsThioredoxins

Identifiers

PMID15181236
OpenAlexW2042263688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.